Steno2tech - Continuous Glucose Monitoring and Type 2 Diabetes.

NACompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2023

Conditions
Type 2 Diabetes Treated With Insulin
Interventions
DEVICE

CGM

Using the CGM during the entire study period of 12 months.

BEHAVIORAL

training course

The participants in the three groups will attend a three-hour training course with different content depending on the group allocation. The aim of this training course is to ensure that the participants have the knowledge, support and confidence to work collaboratively with their HCPs to increase TIR and decrease HbA1c.

BEHAVIORAL

Peer-support

The peer-support will be facilitator-led by the primary investigator with peer exchange in group sessions (3 sessions over the study period, 3 hours per session) with 6-8 participants in every group.

Trial Locations (1)

2820

Steno Diabetes Center Copenhagen, Gentofte Municipality

All Listed Sponsors
lead

Steno Diabetes Center Copenhagen

OTHER

NCT04331444 - Steno2tech - Continuous Glucose Monitoring and Type 2 Diabetes. | Biotech Hunter | Biotech Hunter